Concepedia
Statistics
Publications
55
Citations
6.2K
H-Index
33
Active since
1988
Affiliations
Icahn School of Medicine at Mount Sinai(Current)
Tisch Hospital
Tisch Cancer Institute
Kindai University
Eisai (United States)
Max W. Sung is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and pharmacology.
Publications per year
1988–2024
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Richard S. Finn, Masafumi Ikeda, Andrew X. Zhu et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +17
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao‐Choy, Ge Ma, Johnny Kao et al. · Cancer Research · 2009 · 531 citations · Full text
Medicine, Immunology, Pharmacology +17
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
Sasan Roayaie, Jonathan D. Schwartz, Max W. Sung et al. · Liver Transplantation · 2004 · 463 citations
Medicine, Oncology, Surgery +17
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text
Medicine, Oncology, Pharmacology +12
Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters
Sasan Roayaie, Jason S. Frischer, Sukru Emre et al. · Annals of Surgery · 2002 · 389 citations · Full text
Medicine, Oncology, Surgery +16
1–5 of 55